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ublishedPURPOSE: To compare the central postoperative vault of a phakic intraocular lens (pIOL) to correct
myopia, myopic astigmatism, and hyperopia and identify ocular and lens parameters that might
predict the vault amount.
SETTING: Fernandez-Vega Ophthalmological Institute, Oviedo, Spain.
DESIGN: Cohort study.
METHODS: Three months after implantation of Implantable Collamer Lens pIOLs to correct myopia,
hyperopia, and myopic astigmatism, central vault was measured using optical coherence tomogra-
phy. Patients were divided into groups according to the preoperative anterior chamber depth (ACD)
to compare the effects of ACD, white-to-white (WTW) distance, and lens diameter on postoperative
pIOL vault.
RESULTS: Hyperopic pIOLs had statistically significantly lower vault followed by myopic pIOLs and
toric pIOLs, which had a higher mean value and narrower range (260 to 860 mm). Measured vaults
had a positive correlation with preoperative ACD (rZ .32, P<.001) and WTW (rZ .29, P<.001) and
a negative correlation with preoperative spherical equivalent (SE) (rZ 0.21, P<.001) and patient
age (rZ0.12, PZ.025). Eyes with a vault of 250 mm or less had a shallower ACD than eyes with
a vault between 250 mm and 750 mm (mean difference0.11 mm; PZ.012) and those with a vault
greater than 750 mm (mean difference 0.25 mm; P<.001).
CONCLUSIONS: Central vaulting was lower in hyperopic eyes. Current nomograms for pIOL diam-
eter selection based on ACD and WTW might yield ideal vault and may have to be adjusted for older
patients, shallower ACD, lower WTW, and lower SE.
Financial Disclosure: No author has a financial or proprietary interest in any material or method
mentioned.
J Cataract Refract Surg 2012; 38:46–53 Q 2012 ASCRS and ESCRSIn many cases, phakic intraocular lens (pIOL) implan-
tation is a good alternative treatment for ametropia
correction, and the technique has become an important
refractive surgery option. The Visian Implantable
Collamer Lens (Staar Surgical Co.) is a foldable pIOL
designed to be placed in the posterior chamber behind
the iris with the haptic zone resting on the ciliary
sulcus. Studies have found this pIOL to be safe and
effective in the refractive correction of myopia,1
hyperopia,2 and astigmatism3–5 and in eyes that
may not be appropriate for corneal reshapingSCRS and ESCRS
by Elsevier Inc.procedures.6–8 Results in long-term studies confirm
these results.9
The most important way to avoid pIOL-induced
complications, such as pupillary block10 and cataract
formation,11 is to achieve the proper distance between
the back pIOL surface and the anterior crystalline lens
pole; this distance, called vault, is dependent on the
chosen pIOL diameter. At present, the diameter of
the pIOL is determined based on the horizontal
white-to-white (WTW) distance, anterior chamber
depth (ACD), and manufacturer’s recommendations.0886-3350/$ - see front matter
doi:10.1016/j.jcrs.2011.07.035
47CENTRAL VAULT AFTER PHAKIC IOL IMPLANTATIONThe ideal vault is between 1.0 and 1.5 corneal thick-
nesses on slitlamp examination. However, choosing
the pIOL diameter based on WTW has limitations;
thus, it is not likely that conventional methods will
give accurate vault values, specifically in eyes with
a large WTW distance or a shallower ACD.12
The present study assessed the effects of ocular pa-
rameters (ACD and WTW values) and pIOL diameter
on postoperative vault and evaluated the factors that
affect central vault after pIOL implantation in eyes
with myopia, hyperopia, or astigmatism.
PATIENTS AND METHODS
This study comprised patients having pIOL implantation at
the Fernandez-Vega Ophthalmological Institute, Oviedo,
Spain, from August 2006 to May 2009. After being fully
informed of the details and possible risks of the surgical
procedure, all patients provided written informed consent.
The study followed the Declaration of Helsinki, and an insti-
tutional review board approved the study.
The inclusion criteria for pIOL implantation were
a corrected distance visual acuity (CDVA) of 20/50 or better,
a stable refraction, andaclear central cornea.Theexclusioncri-
teria were age over 22 years, an ACD less than 2.8mm, an en-
dothelial cell density (ECD) more than 2000 cells/mm2,
cataract, a history of glaucoma or retinal detachment, macu-
lar degeneration or retinopathy, neuro-ophthalmic disease,
and a history of ocular inflammation.
Before pIOL implantation, patients had a complete oph-
thalmologic examination. The examination included the
manifest and cycloplegic refractions, keratometry, corneal
topography and pachymetry (Orbscan II, Bausch & Lomb),
ECD measurement (SP 3000P, Topcon Europe BV), slitlamp
evaluation, Goldmann applanation tonometry, and binocu-
lar indirect ophthalmoscopy through a dilated pupil.Phakic Intraocular Lens Size and Power CalculationA Visian Implantable Collamer Lens pIOL was used in all
cases. The pIOL is rectangular, 7.0mmwide, and available inSubmitted: January 4, 2011.
Final revision submitted: July 21, 2011.
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J CATARACT REFRACT SURG -4 overall lengths: 11.5mm, 12.0mm, 12.5mm, and 13mm for
the myopic model (ICMV4) and toric model (TICMV4) and
11.0 mm, 11.5 mm, 12.0 mm, and 12.5 mm for the hyperopic
model (ICHV3). All eyes had implantation of the most recent
pIOL model and, when possible, were targeted for
emmetropia.
The pIOL diameter was individually determined based on
the horizontal WTW distance and ACD, measured from the
endothelium with the Orbscan II device and following the
pIOL manufacturer’s recommendations. For eyes with an
ACD measurement of 3.5 mm or less, the IOL size was
calculated by adding 0.5 mm to the horizontal WTW mea-
surement. For eyes with an ACD measurement greater
than 3.5 mm, up to 1.0 mmwas added to theWTWmeasure-
ment. Calculated IOL sizes between the available IOL diam-
eters (in 0.5 mm steps) were usually rounded down if the
ACDwas 3.5 or less and rounded up if the ACDwas greater
than 3.5mm. The pIOL powerwas calculated using the pIOL
power table software provided by the manufacturer and
amodified vertex formula. The pIOL implantation technique
has been reported.13,14Vault AssessmentThe central separation between the anterior lens surface
and the posterior pIOL surface (vault) was assessed using
optical coherence tomography (OCT) (Visante, Carl Zeiss
Meditec AG). The separation was measured perpendicular
to the lens apex or at the narrowest space between the 2 sur-
faces. All vault measures were performed during the routine
visit 3 months postoperatively.
All vault measures were taken under the same lighting
conditions and with cycloplegia to avoid the potential influ-
ence of accommodation-induced changes in the position of
the anterior surface of the crystalline lens or the pIOL, which
could affect the estimation of the amount of vault. The same
technician took multiple measurements and calculated the
mean value.
To compare the effects of ACD,WTW, and pIOL diameter,
patients were divided into several subgroups according to
the preoperative ACD (%3.17 mm or O3.17 mm), WTW
diameter (%11.7 mm or O11.7 mm), and the difference
between the pIOL diameter and WTW (%0.5 mm or
O0.5 mm). Cutoff values were arbitrarily set based on the
median preoperative ACD (3.17 mm), median WTW diame-
ter (11.7 mm), and median difference betweenWTW and the
chosen pIOL diameter (0.5 mm).
As in previous studies,15–17 the eyeswere also divided into
groups based on the vault value. Ideal vault was defined as
250 to 750 mm, excessive vault as more than 750 mm, and
insufficient vault as less than 250 mm.Statistical AnalysisStatistical analysis was performed using SPSS for
Windows software (version 18.0, SPSS, Inc.). Descriptive sta-
tistics were obtained. The Kolmogorov-Smirnov test was
used to evaluate the normality of the data distribution. The
Kruskal-Wallis test was used to determine statistically signif-
icant differences in vault between the 3 pIOL models (ie,
myopic, hyperopic, toric). The Mann-Whitney U test and
analysis of variance (ANOVA), with multiple comparisons
(with Bonferroni post hoc correction of P values) where
appropriate, were used to determine statistically significant
differences between the stratified subgroups. TheVOL 38, JANUARY 2012
Table 1. Patient demographics, pIOL characteristics, and postoperative visual and refractive outcomes.
Myopic pIOL Group Hyperopic pIOL Group
Parameter P Value* P Value*
Eyes (n) 323 d d 28 d d
Age (y) 31.3G 7.0 21, 46 .001 30.2G 6.8 20, 47 .322
Sphere (D) 8.40G 3.49 19.00, 0.50 .002 4.71G 1.94 C1.00,C8.25 .825
Cylinder (D) 1.20G 1.09 2.50, 0.00 !.001 1.46G 1.28 4.00, 0.00 .159
ACD (mm) 3.28G 0.38 2.89, 4.03 .888 3.02G 0.23 2.83, 3.40 .749
WTW (mm) 11.8G 0.3 11.2, 12.5 .007 11.9G 0.3 11.3, 12.4 .424
pIOL diameter (mm) 12.2G 0.3 11.5, 12.5 !.001 11.9G 0.3 12.5, 11.5 .028
CDVA 0.88G 0.17 0.40, 1.00 !.001 0.92G 0.12 0.70, 1.00 .004
Postoperative
SE (D) 0.25G 0.61 5.00, 1.50 !.001 0.05G 0.57 2.00, 1.25 .005
UDVA (Snellen lines) 0.83G 0.23 0.4, 1.0 !.001 0.87G 0.17 0.3, 1.0 .124
CDVA (Snellen lines) 0.92G 0.14 0.4, 1.0 !.001 0.92G 0.11 0.7, 1.0 .004
ACDZ anterior chamber depth; CDVAZ corrected distance visual acuity; pIOLZ phakic intraocular lens; SEZ spherical equivalent;
UDVAZ uncorrected distance visual acuity; WTWZ white-to-white distance
*One-sample Kolmogorov-Smirnov test
†Between groups; Kruskal-Wallis test
48 CENTRAL VAULT AFTER PHAKIC IOL IMPLANTATIONcorrelations between pIOL vault and the preoperative ACD,
the WTW diameters, and the differences in the pIOL and
WTW diameters were analyzed using Spearman rank corre-
lation coefficient (r) analysis. Differences were considered
statistically significant when the P value was less than 0.05.RESULTS
The study enrolled 371 eyes of 196 patients (116
women [59.2%]). Table 1 shows patients’ demograph-
ics, pIOL characteristics, and postoperative visual and
refractive outcomes by pIOL type (ie, myopic, hyper-
opic, toric). Therewas no statistically significant differ-
ence in the postoperative spherical equivalent (SE),
uncorrected distance visual acuity (PZ.209), or
CDVA (PZ.342) between the 3 pIOL groups.
The mean baseline postoperative vault was highest
in the toric pIOL group (mean 493 mm G 161 [SD];
range 260 to 860 mm) and lowest in the hyperopic
pIOL group (mean 371 G 183 mm; range 140 to 850
mm). The mean vault was 448G 22 mm in the myopic
pIOL group, and this group had the lowest value and
the highest value (range 100 to 1060 mm). The differ-
ence between the 3 pIOL groups was statistically sig-
nificant (P!.001, Kruskal-Wallis test), as were the
differences between the myopic pIOL group and
the hyperopic pIOL group (PZ.04, Mann-Whitney
U test) and between the hyperopic pIOL group and
the toric pIOL group (PZ.02, Mann-Whitney U
test). Measured vaults had a positive correlation
with preoperative ACD (r Z 0.32, P!.001) and
WTW (r Z 0.29, P!.001) (Figure 1, A and B) and
a negative correlation with preoperative SE (r ZJ CATARACT REFRACT SURG -0.21, P!.001) and patient age (r Z 0.12,
PZ.025) (Figure 1, C and D).
Table 2 compares the vault in the subgroups (ie,
stratified by ACD, WTW, and difference between
pIOL diameter andWTW). In the myopic pIOL group,
the mean measured vault in the ACD%3.17 mm sub-
group was significantly statistically lower than in the
ACDO3.17 mm subgroup (PZ.011); no significantly
statistically difference was found between the
2 WTW subgroups. In the hyperopic pIOL group,
themeanmeasured vault was significantly statistically
lower in the ACD %3.17 mm subgroup than in the
ACD O3.17 mm subgroup and significantly statisti-
cally lower in the WTW%11.7 mm subgroup than in
the WTWO11.7 mm subgroup (both P!.001); no sta-
tistically significant difference was found between the
2 subgroups stratified by the difference betweenWTW
and lens diameter (PZ.551). In the toric pIOL group,
there were no statistically significant differences in
the mean vault between the 2 ACD groups (PZ.314),
the 2 WTW subgroups (PZ.275), or the 2 subgroups
stratified by the difference between WTW and lens
diameter (PZ.615).
Table 3 compares the ACD and WTW values in the
myopic pIOL group stratified by the amount of post-
operative vault. Eyes with a vault between 250 mm
and 750 mm and eyes with a vault of more than
750 mm had a deeper ACD than eyes with a vault
less than 250 mmbyC0.11mm (PZ.012) andC0.25mm
(P!.001), respectively. In addition, eyes with a vault
less than 250 mm had a significantly lower WTW diam-
eter than eyes with a postoperative vault more than
750 mm (mean difference 0.22 mm) (PZ.011).VOL 38, JANUARY 2012
Toric pIOL Group
P Value* P Value†
20 d d d
31.9G 5.7 24, 42 .534 .563
6.41G 3.06 11.00, 0.00 .772 !.001
2.89G 1.21 5.00, 1.00 .910 !.001
3.37G 0.30 2.93, 3.99 .648 .001
12.0G 0.4 11.5, 12.9 .622 !.001
12.4G 0.3 13.0, 12.0 .008 !.001
0.82G 0.21 0.40, 1.00 .157 .342
0.23G 0.38 1.50, 0.00 .191 .100
0.75G 0.24 0.3, 1.0 .449 .209
0.87G 0.18 0.4, 1.0 .114 .342
Table 1. (Cont.)
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The present study found that the mean central vault
with the 3 types of Implantable Collamer Lens pIOLs
was different. The hyperopic pIOLs had the lowest
mean values and the toric pIOLs the highest mean
values. This agrees with previous findings18,19 and is
the result of the inherent design of each pIOL type
and of the different anatomy of hyperopic, myopic,
and astigmatic eyes. The myopic pIOL is plano con-
cave, with the plano surface facing anteriorly, and it
has an optic diameter ranging from 4.65 to 5.50 mm.
The toric pIOL for astigmatism has a similar design
but incorporates cylinder in the posterior optic zone.
The hyperopic pIOL is meniscus-shaped (concave–
convex), with a convex anterior surface and a 5.5 mm
optic diameter; the central thickness is much greater
than that of the myopic pIOL. In addition, hyperopic
eyes have a more crowded anterior segment than my-
opic eyes. These differences may explain the difference
in the vault we observed.
We had observed that the ideal vault was not
reached in some cases when we followed the recom-
mendations of the Implantable Collamer Lens pIOL
manufacturer. Thus, we focused on the effect of
ACD and WTW, which were shown to have signifi-
cant correlations with the amount of postoperative
vault, and assessed the efficacy of the conventional
method. For the hyperopic pIOL, ACD was the most
significant parameter associated with vault; eyes
with a lower ACD had significantly lower vault. For
the myopic pIOL, significant differences were found
between the ACD subgroups and between the WTWJ CATARACT REFRACT SURG -subgroups. Eyeswith a shallowerACDand/or a lower
WTW had significantly lower vault; conversely eyes
with a deeper ACD and/or a higher WTW had signif-
icantly higher vault. This agrees with the findings of
Seo et al.,12 who report that a high WTW diameter or
a deep ACD are likely to result in high vault, regard-
less of differences in pIOL diameter and sulcus
diameter.
According to the manufacturer’s recommendations,
the pIOL diameter should be 0.5 to 1.0 mm larger than
the WTW measurement in myopic eyes and the same
as or 0.5 mm larger than the WTW in hyperopic
eyes. In addition, the ideal postoperative vault must
create space over the whole anterior crystalline lens
surface, with the recommended amount of vault equal
to 1.0 to 1.5 central corneal thicknesses on slitlamp
examination,20 which corresponds approximately to
a value between 400 mm to 600 mm.13 For this to be
achieved, the appropriate pIOL must be selected.
Underestimating the pIOL diameter is frequently asso-
ciated with poor vault (!250 mm) immediately after
surgery.17 This increases the risk for cataract develop-
ment, which is caused by pIOL–crystalline lens contact
or by disturbances in aqueous flow, which interferes
with lens nutrition and thus results in metabolic dis-
turbances to the crystalline lens.11,21,22 On the other
hand, excessive vault (O750 mm)17 can cause angle-
closure, pupillary block glaucoma, or pigmentary-
dispersion glaucoma and is often associated with an
oversized pIOL.23–25 Moreover, the anterior segment
(including anterior chamber and posterior chamber)
is a dynamic rather than static space. Thus, factors
such as accommodation and biometric ocular changesVOL 38, JANUARY 2012
Table 2. Subgroup comparisons of ACD, WTW, and difference between WTW and lens diameter.
ACD WTW WTW  LD
Group/Parameter %3.17 mm O3.17 mm P Value* %11.7 mm O11.7 mm P Value* %0.5 mm O0.5 mm P Value*
Myopic group
pIOL diameter (mm) 11.88G 0.36 12.00G 0.00 .340 11.75G 0.42 12.06G 0.24 .016 11.90G 0.32 d d
Vault (mm) 301G 119 534G 197 .011 315G 122 403G 205 .388 366G 188 d d
Hyperopic group
pIOL diameter (mm) 12.07G 0.29 12.29G 0.26 !.001 12.03G 0.24 12.36G 0.25 .000 12.14G 0.30 12.24G 0.27 .010
Vault (mm) 386G 189 507G 232 !.001 390G 187 512G 240 .000 440G 209 469G 242 .551
Toric group
pIOL diameter (mm) 12.33G 0.29 12.47G 0.30 .477 12.20G 0.27 12.53G 0.23 .017 12.45G 0.35 12.50G 0.00 .707
Vault (mm) 573G 176 479G 171 .314 542G 94 476G 178 .275 497G 159 477G 214 .615
ACDZ anterior chamber depth; pIOLZ phakic intraocular lens; LDZ lens diameter; WTWZ white-to-white distance
*Mann-Whitney U test (in myopic group, no statistical analyses between WTW – LD because all myopic pIOL diameters chosen by adding%0.5 mm to WTW)
Figure 1. Correlations between vault and preoperative biometry (ICHZ hyperopic pIOL group; ICMZ myopic pIOL group; TICMZ toric
pIOL group).
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Table 3. Mean differences in preoperative ACD and WTW in the myopic pIOL group stratified by postoperative vault amount.
Group 1: Vault%250 mm (nZ 65)
Versus
Parameter MeanG SD 95% CI Group 2 P Value* Group 3 P Value*
ACD (mm) 3.05G 0.23 2.99, 3.10 0.11 0.012 0.24 !.001
WTW (mm) 11.62G 0.33 11.54, 11.70 0.09 0.206 0.22 .011
ACDZ anterior chamber depth; CIZ confidence interval for mean; WTWZ white-to-white distance
*Statistically significance for differences between stratified groups
51CENTRAL VAULT AFTER PHAKIC IOL IMPLANTATIONrelated to aging affect the space available between the
posterior cornea and anterior crystalline lens surface,
which in turn affects the amount of vault.14,19,26–30
Thus, achieving satisfactory vault is important for
safe and successful pIOL implantation. In the U.S.
Food and Drug Administration Implantable Collamer
Lens study,31 which implemented the WTWmeasure-
ment protocol, the pIOL replacement rate because of
clinically significant oversizing or undersizing was
1.5%. In the present study, although no pIOL was re-
placed, 70 eyes (18.9%) had a vault less than 250 mm
and 32 eyes (8.6%) had a vault of more than 750 mm.
Eyes with a lower vault had an ACD less than
3.10 mm, while eyes with vaults more than 750 mm
had a WTW greater than 11.76 mm (Table 3).
Patient-dependent factors, such as age and higher
myopia, were correlated with the amount of postoper-
ative vault. Kamiya et al.32 found patient age and
WTW to be the most significant factors affecting vault;
that is, eyes of younger patients and eyeswith a greater
WTW were more likely to have greater vault. In the
present study, there was a statistically significant neg-
ative correlation between postoperative vault and age
(rZ 0.12, PZ.025) and between postoperative vault
and SE (rZ 0.21, P!.001); older patients had lower
vault, while patients with higher degrees of myopia
tended to have higher vault. The reason is that the an-
terior chamber decreases in the aging eye because of
the thickening of the aging crystalline lens.33 This re-
sults in lower vault, and the thicker periphery of
highly powered pIOLs causes anterior chamber nar-
rowing because of an iris forward shift; these factors
result in excessive vault.
Because the haptics of the Visian Implantable Col-
lamer Lens pIOL rest in the ciliary sulcus, the ideal
overall diameter of pIOL depends on the ciliary sulcus
diameter. Thus, it is desirable to obtain a direct
measurement of the sulcus-to-sulcus length using
new imaging technologies such as ultrasound biomi-
croscopy (UBM).34 However, regardless of the accu-
racy of the WTW measurement, recent studies35–38J CATARACT REFRACT SURG -found no anatomic correlation between external mea-
surements and internal dimensions. Therefore, WTW
distance alone may not predict angle or sulcus size,
and the horizontal diameter of the ciliary sulcus
may not be accurately predicted, resulting in size mis-
matching. Moreover, it has been reported that UBM
determination of pIOL length yields significantly bet-
ter vault than the conventional WTW method.16 Al-
though using UBM might provide better outcomes
than WTW measurements, there is still a risk for
high or low vaulting resulting from incorrect position-
ing of the pIOL in the sulcus.39 In the present study,
the pIOL diameter was chosen according to the
WTW diameter, and we could not accurately predict
the exact position of the pIOL in the sulcus. However,
the results in our study reflect the postoperative vault
surgeons might expect when they use the current no-
mogram and select pIOL diameter based on WTW
and ACD measurements. Our results suggest that in
some cases, the current nomogram to select pIOL di-
ameter might not yield ideal vault, particularly in
eyes with a shallower ACD (%3.1 mm) and lower
WTW diameter (11.5 mm) and in eyes with a large
WTW diameter (O11.8 mm).
A limitation of this study is the discrepancy in sam-
ple size. Despite the results of a power analysis that
showed the sample size was not big enough to confirm
statistically significant differences between the 3 pIOL
models, the results in our study show the vault behav-
ior with the myopic, hyperopic, and toric models and
the correlation between vaulting and ocular
parameters.
In conclusion, the results indicate that the current
nomogram for pIOL sizing does not always yield ideal
vault and that it requires adjustment in certain cases, in
particular for older eyes, eyes with a shallow ACD,
eyes with a lower WTW distance, and eyes with
a lower SE. Additional studies using UBM to select
the pIOL diameter may help to achieve uniform vault
regardless of preoperative ocular dimensions andmay
prevent poor or excessive vault.VOL 38, JANUARY 2012
Group 2: Vault 250–750 mm (nZ 227) Group 3: VaultO750 mm (nZ 31)
Versus
MeanG SD 95% CI Group 3 P Value* MeanG SD 95% CI
3.16G 0.31 3.12, 3.20 0.12 .111 3.28G 0.29 3.17, 3.39
11.71G 0.37 11.66, 11.76 0.13 .145 11.84G 0.23 11.76, 11.92
Table 3. (Cont.)
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